May 23, 2018 PR-M05-18-NI-085
BALTIMORE, May 18, 2018 /PRNewswire/ -- Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the 2018 Life Science Company of the Year by the Maryland Tech Council (MTC). The announcement came at MTC's 30th Annual Industry Awards held last night in the Hotel at the University of Maryland in College Park.
"We are incredibly honored to accept the Life Science Company of the Year award from the Maryland Tech Council," said Pete Buzy, President and CEO. "We have a very talented team and world-class customers – and we're proud of what we've accomplished to date. Receiving this honor on the heels of our recent commercial manufacturing facility expansion announcement is a true win."
Paragon announced its plans for expansion earlier this year, including late-phase and commercial manufacturing capabilities. The company has acquired a new 150,000-square-foot process development and cGMP manufacturing facility outside of Baltimore, convenient to Baltimore/Washington International (BWI) Thurgood Marshall Airport.
Corporate Contact
Philip Wills, Chief Commercial Officer
PH (410) 975-4050
Media Contact
Juliette Bogus
PH (410) 980-5687
Juliette.bogus@gmail.com
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.